Literature DB >> 3796831

Caffeine and tremor.

W Koller, S Cone, G Herbster.   

Abstract

Two percent of normal controls noted that drinking coffee made their hands shaky. Eight percent of essential tremor and 6% of Parkinson's disease patients thought that coffee worsened their tremor. In formal tests, a single oral dose of caffeine (325 mg) did not increase physiologic, essential tremor, or parkinsonian tremor at 1, 2, or 3 hours after ingestion. Caffeine only infrequently induces tremor in normal people, and it does not exacerbate pathologic tremor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3796831     DOI: 10.1212/wnl.37.1.169

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

Review 1.  Differential diagnosis of common tremor syndromes.

Authors:  R Bhidayasiri
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

2.  Caffeine Consumption in First-Degree Relatives of Essential Tremor Cases: Evidence of Dietary Modification Before Disease Onset.

Authors:  Elan D Louis; James H Meyers; Ashley D Cristal; Pam Factor-Litvak
Journal:  Neuroepidemiology       Date:  2018-06-28       Impact factor: 3.282

3.  Effects of acute hypoxia on postural and kinetic tremor.

Authors:  A Legros; H R Marshall; A Beuter; J Gow; B Cheung; A W Thomas; F S Prato; R Z Stodilka
Journal:  Eur J Appl Physiol       Date:  2010-04-23       Impact factor: 3.078

4.  Effects of A 60 Hz Magnetic Field of Up to 50 milliTesla on Human Tremor and EEG: A Pilot Study.

Authors:  Shirin Davarpanah Jazi; Julien Modolo; Cadence Baker; Sebastien Villard; Alexandre Legros
Journal:  Int J Environ Res Public Health       Date:  2017-11-24       Impact factor: 3.390

5.  Gender-dependent effect of coffee consumption on tremor severity in de novo Parkinson's disease.

Authors:  Bang-Hoon Cho; Seong-Min Choi; Byeong C Kim
Journal:  BMC Neurol       Date:  2019-08-14       Impact factor: 2.474

6.  Coffee break has no impact on laparoscopic skills: a randomized double-blinded placebo-controlled parallel-group trial.

Authors:  Christoph Gerdes; Anna Maria Berghäuser; Julian Hipp; Martin Bäumlein; Svenja Hinrichs; Jan-Christoph Thomassen; Sebastian Hoffmann; Berthold Gerdes
Journal:  Surg Endosc       Date:  2021-08-30       Impact factor: 4.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.